Page last updated: 2024-08-23

staurosporine and lrrk2-in1

staurosporine has been researched along with lrrk2-in1 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doddareddy, MR; Kassiou, M; Kavanagh, ME	1
Baekelandt, V; Göring, S; Schmidt, B; Taymans, JM	1

Other Studies

2 other study(ies) available for staurosporine and lrrk2-in1

Article	Year
The development of CNS-active LRRK2 inhibitors using property-directed optimisation. Bioorganic & medicinal chemistry letters, 2013, Jul-01, Volume: 23, Issue:13 Topics: Central Nervous System; Central Nervous System Agents; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Molecular Structure; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Structure-Activity Relationship	2013
Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond. Bioorganic & medicinal chemistry letters, 2014, Oct-01, Volume: 24, Issue:19 Topics: Animals; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Indoles; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Molecular Structure; Phenotype; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins	2014

Article

Year

The development of CNS-active LRRK2 inhibitors using property-directed optimisation.

Bioorganic & medicinal chemistry letters, 2013, Jul-01, Volume: 23, Issue:13

Topics: Central Nervous System; Central Nervous System Agents; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Molecular Structure; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Structure-Activity Relationship

2013

Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond.

Bioorganic & medicinal chemistry letters, 2014, Oct-01, Volume: 24, Issue:19

Topics: Animals; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Indoles; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Molecular Structure; Phenotype; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins

2014